NEW YORK (Reuters Health), Apr 23 - Transesophageal echocardiography (TEE) can shed light on contributing cardiogenic factors in patients with cryptogenic cerebral ischemia, according to German and U.S. researchers.
In a March 28 online publication in Cardiovascular Ultrasound, Dr. Fabian Knebel of Charité Medical University Berlin and colleagues note that in about one-third of patients with cerebral ischemia, no definite cause can be identified.
To evaluate the prevalence of abnormal echocardiographic findings in these patients, the researchers studied TEE results on 702 patients with ischemic stroke or a transient ischemic attack (TIA). Subjects also underwent a variety of other clinical and laboratory tests.
In more than half of patients (52.6%), TEE provided relevant findings. The most common overall were patent foramen ovale (21.7%) and previously undiagnosed valvular disease (15.8%). Other findings included aortic valve sclerosis and atrial septal defects.
Patients older than 55 years and patients with ischemic stroke had more relevant echocardiographic findings than younger patients or those with TIA.
Patent foramen ovale was more common in younger patients, however (26.8% versus 18.0%). This was also true of atrial septal defects (9.6% versus 4.9%).
Dr. Knebel told Reuters Health that given these findings, "it appears that TEE examinations are indicated in all patients with cryptogenic stroke, regardless of their age."
By David Douglas
Cardiovasc Ultrasound 2009.
Last Updated: 2009-04-22 14:24:36 -0400 (Reuters Health)
Related Reading
Patent foramen ovale linked to cryptogenic stroke in older patients, December 3, 2007
Copyright © 2009 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.
